MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.3800
-0.0400 (-9.52%)
At close: Jun 12, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 2.77 million as of June 12, 2026. Its market cap has increased by 29.06% in one year.
Market Cap
2.77M
Enterprise Value
4.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.38
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 2.77M, a decrease of -96.53%. That is a compound annual growth rate of -66.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 2.77M | -53.82% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovotech | 5.72M |
| Aptose Biosciences | 5.59M |
| Restart Life Sciences | 5.50M |
| PharmaTher Holdings | 5.46M |
| MYND Life Sciences | 5.22M |
| Rakovina Therapeutics | 3.42M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.06M |